• レポートコード:QYR9N7905 • 出版社/出版日:QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、98ページ • 納品方法:Eメール(受注後2~3営業日) • 産業分類:医療・製薬・バイオ |
Single User | ¥585,000 (USD3,900) | ▷ お問い合わせ |
Enterprise License | ¥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当資料は、向精神薬のグローバル市場について調査・分析したレポートで、種類別(抗うつ剤、抗精神病薬、覚せい剤、抗不安薬、気分安定剤)、用途別(病院薬局、ドラッグストア、小売店、Eコマース)、主要地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米)の市場規模、市場予測、関連企業情報などが含まれています。 ・向精神薬の世界市場規模 ・主要企業別市場シェア ・向精神薬の世界市場規模:種類別(抗うつ剤、抗精神病薬、覚せい剤、抗不安薬、気分安定剤) ・向精神薬の世界市場規模:用途別(病院薬局、ドラッグストア、小売店、Eコマース) ・向精神薬のアメリカ市場規模(種類別、用途別) ・向精神薬のヨーロッパ市場規模(種類別、用途別) ・向精神薬の中国市場規模(種類別、用途別) ・向精神薬の日本市場規模(種類別、用途別) ・向精神薬の東南アジア市場規模(種類別、用途別) ・向精神薬のインド市場規模(種類別、用途別) ・向精神薬の中南米市場規模(種類別、用途別) ・主要企業別分析(企業概要、製品動向、販売量など) ・向精神薬の世界市場予測(2019年-2025年) ・向精神薬の地域別市場予測(2019年-2025年) ... |
Psychotropic pharmaceutical is a chemical substance that changes brain function and results in alterations in perception, mood, consciousness, cognition or behavior.The global psychotropic pharmaceuticals market is expected to grow rapidly over the forecast period owing to the raising prevalence of mental disorders.
In 2018, the global Psychotropic Pharmaceuticals market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Psychotropic Pharmaceuticals status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Psychotropic Pharmaceuticals development in United States, Europe and China.
The key players covered in this study
Teva Pharmaceuticals
Novartis
Mylan
AstraZeneca
Sun Pharmaceuticals
…
Market segment by Type, the product can be split into
Anti-Depressants
Anti-Psychotics
Stimulants
Anxiolytics
Mood Stabilizers
Market segment by Application, split into
Hospital Pharmacies
Drug Stores
Retail Stores
E-Commerce
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Psychotropic Pharmaceuticals status, future forecast, growth opportunity, key market and key players.
To present the Psychotropic Pharmaceuticals development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Psychotropic Pharmaceuticals are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Psychotropic Pharmaceuticals Market Size Growth Rate by Type (2014-2025)
1.4.2 Anti-Depressants
1.4.3 Anti-Psychotics
1.4.4 Stimulants
1.4.5 Anxiolytics
1.4.6 Mood Stabilizers
1.5 Market by Application
1.5.1 Global Psychotropic Pharmaceuticals Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Drug Stores
1.5.4 Retail Stores
1.5.5 E-Commerce
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Psychotropic Pharmaceuticals Market Size
2.2 Psychotropic Pharmaceuticals Growth Trends by Regions
2.2.1 Psychotropic Pharmaceuticals Market Size by Regions (2014-2025)
2.2.2 Psychotropic Pharmaceuticals Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Psychotropic Pharmaceuticals Market Size by Manufacturers
3.1.1 Global Psychotropic Pharmaceuticals Revenue by Manufacturers (2014-2019)
3.1.2 Global Psychotropic Pharmaceuticals Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Psychotropic Pharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.2 Psychotropic Pharmaceuticals Key Players Head office and Area Served
3.3 Key Players Psychotropic Pharmaceuticals Product/Solution/Service
3.4 Date of Enter into Psychotropic Pharmaceuticals Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Psychotropic Pharmaceuticals Market Size by Type (2014-2019)
4.2 Global Psychotropic Pharmaceuticals Market Size by Application (2014-2019)
5 United States
5.1 United States Psychotropic Pharmaceuticals Market Size (2014-2019)
5.2 Psychotropic Pharmaceuticals Key Players in United States
5.3 United States Psychotropic Pharmaceuticals Market Size by Type
5.4 United States Psychotropic Pharmaceuticals Market Size by Application
6 Europe
6.1 Europe Psychotropic Pharmaceuticals Market Size (2014-2019)
6.2 Psychotropic Pharmaceuticals Key Players in Europe
6.3 Europe Psychotropic Pharmaceuticals Market Size by Type
6.4 Europe Psychotropic Pharmaceuticals Market Size by Application
7 China
7.1 China Psychotropic Pharmaceuticals Market Size (2014-2019)
7.2 Psychotropic Pharmaceuticals Key Players in China
7.3 China Psychotropic Pharmaceuticals Market Size by Type
7.4 China Psychotropic Pharmaceuticals Market Size by Application
8 Japan
8.1 Japan Psychotropic Pharmaceuticals Market Size (2014-2019)
8.2 Psychotropic Pharmaceuticals Key Players in Japan
8.3 Japan Psychotropic Pharmaceuticals Market Size by Type
8.4 Japan Psychotropic Pharmaceuticals Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Psychotropic Pharmaceuticals Market Size (2014-2019)
9.2 Psychotropic Pharmaceuticals Key Players in Southeast Asia
9.3 Southeast Asia Psychotropic Pharmaceuticals Market Size by Type
9.4 Southeast Asia Psychotropic Pharmaceuticals Market Size by Application
10 India
10.1 India Psychotropic Pharmaceuticals Market Size (2014-2019)
10.2 Psychotropic Pharmaceuticals Key Players in India
10.3 India Psychotropic Pharmaceuticals Market Size by Type
10.4 India Psychotropic Pharmaceuticals Market Size by Application
11 Central & South America
11.1 Central & South America Psychotropic Pharmaceuticals Market Size (2014-2019)
11.2 Psychotropic Pharmaceuticals Key Players in Central & South America
11.3 Central & South America Psychotropic Pharmaceuticals Market Size by Type
11.4 Central & South America Psychotropic Pharmaceuticals Market Size by Application
12 International Players Profiles
12.1 Teva Pharmaceuticals
12.1.1 Teva Pharmaceuticals Company Details
12.1.2 Company Description and Business Overview
12.1.3 Psychotropic Pharmaceuticals Introduction
12.1.4 Teva Pharmaceuticals Revenue in Psychotropic Pharmaceuticals Business (2014-2019)
12.1.5 Teva Pharmaceuticals Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Psychotropic Pharmaceuticals Introduction
12.2.4 Novartis Revenue in Psychotropic Pharmaceuticals Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Mylan
12.3.1 Mylan Company Details
12.3.2 Company Description and Business Overview
12.3.3 Psychotropic Pharmaceuticals Introduction
12.3.4 Mylan Revenue in Psychotropic Pharmaceuticals Business (2014-2019)
12.3.5 Mylan Recent Development
12.4 AstraZeneca
12.4.1 AstraZeneca Company Details
12.4.2 Company Description and Business Overview
12.4.3 Psychotropic Pharmaceuticals Introduction
12.4.4 AstraZeneca Revenue in Psychotropic Pharmaceuticals Business (2014-2019)
12.4.5 AstraZeneca Recent Development
12.5 Sun Pharmaceuticals
12.5.1 Sun Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Psychotropic Pharmaceuticals Introduction
12.5.4 Sun Pharmaceuticals Revenue in Psychotropic Pharmaceuticals Business (2014-2019)
12.5.5 Sun Pharmaceuticals Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Psychotropic Pharmaceuticals Key Market Segments
Table Key Players Psychotropic Pharmaceuticals Covered
Table Global Psychotropic Pharmaceuticals Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Psychotropic Pharmaceuticals Market Size Market Share by Type 2014-2025
Figure Anti-Depressants Figures
Table Key Players of Anti-Depressants
Figure Anti-Psychotics Figures
Table Key Players of Anti-Psychotics
Figure Stimulants Figures
Table Key Players of Stimulants
Figure Anxiolytics Figures
Table Key Players of Anxiolytics
Figure Mood Stabilizers Figures
Table Key Players of Mood Stabilizers
Table Global Psychotropic Pharmaceuticals Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Drug Stores Case Studies
Figure Retail Stores Case Studies
Figure E-Commerce Case Studies
Figure Psychotropic Pharmaceuticals Report Years Considered
Table Global Psychotropic Pharmaceuticals Market Size 2014-2025 (Million US$)
Figure Global Psychotropic Pharmaceuticals Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Psychotropic Pharmaceuticals Market Size by Regions 2014-2025 (Million US$)
Table Global Psychotropic Pharmaceuticals Market Size by Regions 2014-2019 (Million US$)
Table Global Psychotropic Pharmaceuticals Market Share by Regions 2014-2019
Figure Global Psychotropic Pharmaceuticals Market Share by Regions 2014-2019
Figure Global Psychotropic Pharmaceuticals Market Share by Regions 2019
Table Market Top Trends
Table Global Psychotropic Pharmaceuticals Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Psychotropic Pharmaceuticals Market Share by Manufacturers (2014-2019)
Figure Global Psychotropic Pharmaceuticals Market Share by Manufacturers in 2018
Table Global Psychotropic Pharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Psychotropic Pharmaceuticals Product/Solution/Service
Table Date of Enter into Psychotropic Pharmaceuticals Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Psychotropic Pharmaceuticals Market Size by Type (2014-2019) (Million US$)
Table Global Psychotropic Pharmaceuticals Market Size Share by Type (2014-2019)
Figure Global Psychotropic Pharmaceuticals Market Size Market Share by Type (2014-2019)
Table Global Psychotropic Pharmaceuticals Market Size by Application (2014-2019) (Million US$)
Table Global Psychotropic Pharmaceuticals Market Size Share by Application (2014-2019)
Figure Global Psychotropic Pharmaceuticals Market Size Market Share by Application (2014-2019)
Figure Global Psychotropic Pharmaceuticals Revenue Market Share by Application in 2018
Figure United States Psychotropic Pharmaceuticals Market Size 2014-2019 (Million US$)
Table United States Key Players Psychotropic Pharmaceuticals Revenue (2018-2019) (Million US$)
Table United States Key Players Psychotropic Pharmaceuticals Market Share (2018-2019)
Table United States Psychotropic Pharmaceuticals Market Size by Type (2014-2019) (Million US$)
Table United States Psychotropic Pharmaceuticals Market Share by Type (2014-2019)
Table United States Psychotropic Pharmaceuticals Market Size by Application (2014-2019) (Million US$)
Table United States Psychotropic Pharmaceuticals Market Share by Application (2014-2019)
Figure Europe Psychotropic Pharmaceuticals Market Size 2014-2019 (Million US$)
Table Europe Key Players Psychotropic Pharmaceuticals Revenue (2018-2019) (Million US$)
Table Europe Key Players Psychotropic Pharmaceuticals Market Share (2018-2019)
Table Europe Psychotropic Pharmaceuticals Market Size by Type (2014-2019) (Million US$)
Table Europe Psychotropic Pharmaceuticals Market Share by Type (2014-2019)
Table Europe Psychotropic Pharmaceuticals Market Size by Application (2014-2019) (Million US$)
Table Europe Psychotropic Pharmaceuticals Market Share by Application (2014-2019)
Figure China Psychotropic Pharmaceuticals Market Size 2014-2019 (Million US$)
Table China Key Players Psychotropic Pharmaceuticals Revenue (2018-2019) (Million US$)
Table China Key Players Psychotropic Pharmaceuticals Market Share (2018-2019)
Table China Psychotropic Pharmaceuticals Market Size by Type (2014-20189) (Million US$)
Table China Psychotropic Pharmaceuticals Market Share by Type (2014-2019)
Table China Psychotropic Pharmaceuticals Market Size by Application (2014-2019) (Million US$)
Table China Psychotropic Pharmaceuticals Market Share by Application (2014-2019)
Figure Japan Psychotropic Pharmaceuticals Market Size 2014-2019 (Million US$)
Table Japan Key Players Psychotropic Pharmaceuticals Revenue (2018-2019) (Million US$)
Table Japan Key Players Psychotropic Pharmaceuticals Market Share (2018-2019)
Table Japan Psychotropic Pharmaceuticals Market Size by Type (2014-2019) (Million US$)
Table Japan Psychotropic Pharmaceuticals Market Share by Type (2014-2019)
Table Japan Psychotropic Pharmaceuticals Market Size by Application (2014-2019) (Million US$)
Table Japan Psychotropic Pharmaceuticals Market Share by Application (2014-2019)
Figure Southeast Asia Psychotropic Pharmaceuticals Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Psychotropic Pharmaceuticals Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Psychotropic Pharmaceuticals Market Share (2018-2019)
Table Southeast Asia Psychotropic Pharmaceuticals Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Psychotropic Pharmaceuticals Market Share by Type (2014-2019)
Table Southeast Asia Psychotropic Pharmaceuticals Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Psychotropic Pharmaceuticals Market Share by Application (2014-2019)
Figure India Psychotropic Pharmaceuticals Market Size 2014-2019 (Million US$)
Table India Key Players Psychotropic Pharmaceuticals Revenue (2018-2019) (Million US$)
Table India Key Players Psychotropic Pharmaceuticals Market Share (2018-2019)
Table India Psychotropic Pharmaceuticals Market Size by Type (2014-2019) (Million US$)
Table India Psychotropic Pharmaceuticals Market Share by Type (2014-2019)
Table India Psychotropic Pharmaceuticals Market Size by Application (2014-2019) (Million US$)
Table India Psychotropic Pharmaceuticals Market Share by Application (2014-2019)
Figure Central & South America Psychotropic Pharmaceuticals Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Psychotropic Pharmaceuticals Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Psychotropic Pharmaceuticals Market Share (2018-2019)
Table Central & South America Psychotropic Pharmaceuticals Market Size by Type (2014-2019) (Million US$)
Table Central & South America Psychotropic Pharmaceuticals Market Share by Type (2014-2019)
Table Central & South America Psychotropic Pharmaceuticals Market Size by Application (2014-2019) (Million US$)
Table Central & South America Psychotropic Pharmaceuticals Market Share by Application (2014-2019)
Table Teva Pharmaceuticals Company Details
Table Teva Pharmaceuticals Revenue in Psychotropic Pharmaceuticals Business (2014-2019) (Million US$)
Figure Teva Pharmaceuticals Revenue Growth Rate in Psychotropic Pharmaceuticals Business (2014-2019)
Table Teva Pharmaceuticals Recent Development
Table Novartis Company Details
Table Novartis Revenue in Psychotropic Pharmaceuticals Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Psychotropic Pharmaceuticals Business (2014-2019)
Table Novartis Recent Development
Table Mylan Company Details
Table Mylan Revenue in Psychotropic Pharmaceuticals Business (2014-2019)(Million US$)
Figure Mylan Revenue Growth Rate in Psychotropic Pharmaceuticals Business (2014-2019)
Table Mylan Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Psychotropic Pharmaceuticals Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Psychotropic Pharmaceuticals Business (2014-2019)
Table AstraZeneca Recent Development
Table Sun Pharmaceuticals Company Details
Table Sun Pharmaceuticals Revenue in Psychotropic Pharmaceuticals Business (2014-2019)(Million US$)
Figure Sun Pharmaceuticals Revenue Growth Rate in Psychotropic Pharmaceuticals Business (2014-2019)
Table Sun Pharmaceuticals Recent Development
Table Global Psychotropic Pharmaceuticals Market Size by Regions (Million US$) 2019-2025
Figure Global Psychotropic Pharmaceuticals Market Size Share by Regions (2019-2025)
Figure Global Psychotropic Pharmaceuticals Market Size Share by Regions in 2025
Figure United States Psychotropic Pharmaceuticals Market Size Forecast (2019-2025)(Million USD)
Figure Europe Psychotropic Pharmaceuticals Market Size Forecast (2019-2025)(Million USD)
Figure China Psychotropic Pharmaceuticals Market Size Forecast (2019-2025)(Million USD)
Figure Japan Psychotropic Pharmaceuticals Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Psychotropic Pharmaceuticals Market Size Forecast (2019-2025)(Million USD)
Figure India Psychotropic Pharmaceuticals Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Psychotropic Pharmaceuticals Market Size Forecast (2019-2025)(Million USD)
Table Global Psychotropic Pharmaceuticals Market Size by Product (2019-2025) (Million US$)
Figure Global Psychotropic Pharmaceuticals Market Size by Product (2019-2025)
Figure Global Psychotropic Pharmaceuticals Market Size by Product in 2025
Table Global Psychotropic Pharmaceuticals Market Size by Application (2019-2025) (Million US$)
Figure Global Psychotropic Pharmaceuticals Market Size by Application (2019-2025)
Figure Global Psychotropic Pharmaceuticals Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources